CHARLOTTE-Wyeth-Lederle Vaccines of Philadelphia continues to expand its 215-acre manufacturing, research and development campus in Sanford, NC with a new $250 million, 115,000-sf production facility, 80 miles east of Downtown Charlotte.
The campus produces pediatric vaccines that immunize humans against bacterial infections, according to Industrial Information Resources Inc., a Houston-based industry researcher.
The new expansion follows Wyeth-Lederle's completion of a $48 million, 46,000-sf bulk manufacturing structure that produces two new company vaccines, Prevenar and Meningitac. ADP Marshall Inc. of Rumford, RI, a Fluor Daniel company, was the general contractor.
Fluor Daniel of Greenville, NC is the general contractor on the 115,000-sf job. R&D laboratory additions are also under way.
Wyeth is expected to hire 130 additional workers by 2003 when the current work is slated to be completed, according to Information Resources. The site's total workforce will then be 580.
American Home Prudcts Corp., based in Madison, NJ, owns Wyeth along with Whitehall-Robins Healthcare, Fort Dodge Animal Health, Scientific Protein Laboratories Inc. and Immunex. American Home had 2000 sales of $13.3 billion.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
